期刊
CLINICAL CANCER RESEARCH
卷 19, 期 21, 页码 5927-5939出版社
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1078-0432.CCR-13-0018
关键词
-
类别
资金
- National Taiwan University
- National Science Council [NSC-96-2320-B-002-081-MY3]
- National Health Research Institute [NHRI-EX101-9939NI]
Purpose: The IFN-stimulated gene 15 (ISG15)- and ubiquitin-conjugation pathways play roles in mediating hypoxic and inflammatory responses. To identify interaction(s) between these two tumor microenvironments, we investigated the effect of ISG15 on the activity of the master hypoxic transcription factor HIF-1 alpha. Experimental Design: IFN and desferoxamine treatments were used to induce the expression of ISGs and HIF-1 alpha, respectively. Interactions between HIF-1a and the ISG15 and ISGylation system were studied using knockdown of mRNA expression, immunoblotting, coimmunoprecipitation, and pull-down analyses. Effects of the ISG15 and ISGylation system on the HIF-1 alpha-directed processes were examined using reporter, reverse transcription polymerase chain reaction (RT-PCR), and tumorigenic growth assays. Results: We found that the level of the free form of HIF-1 alpha is differentially regulated by IFN treatment, and that the free ISG15 level is lower under hypoxia. Mechanism-directed studies have shown that HIF-1 alpha not only interacts physically with ISG15, but is also ISGylated in multiple domains. ISG15 expression disrupts the functional dimerization of HIF-1 alpha and -1 beta. Subsequently, expression of the ISG15 and/or ISGylation system attenuates HIF-1 alpha-mediated gene expression and tumorigenic growth. Conclusion: In summary, our results revealed cross-talk between inflammatory and hypoxic pathways through the ISGylation of HIF-1 alpha. On the basis of these results, we propose a novel negative feedback loop for the HIF-1 alpha-mediated pathway involving the regulation of HIF-1 alpha via IFN-induced ISGylation. (C) 2013 AACR.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据